শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

ইঙ্গিত

Diascan is a contrast medium used for cranial and spinal magnetic resonance imaging (MRI), as well as general MRI of the body, given by intravenous injection. It enhances contrast and helps visualise abnormal structures or lesions in various parts of the body, including the central nervous system (CNS).

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Gadodiamide is a clear, colourless to pale yellow solution for injection, containing 287 mg of Gadodiamide USP per ml (equivalent to 0.5 mmol/ml).

In Magnetic Resonance Imaging, the visualization of normal and diseased brain and spinal tissue relies partly on differences in radiofrequency signal intensity. Gadodiamide shortens both the T1 and T2 relaxation times of the tissues it reaches. At the doses used clinically, its main effect is on the T1 relaxation time, which results in a brighter (higher-intensity) signal.

Pregnancy & Breastfeeding

Carcinogenesis, Mutagenesis, Impairment of Fertility: Three short-term in vitro genotoxicity assays and one in vivo assay all gave negative results. No long-term studies have been carried out to assess the carcinogenic potential of Gadodiamide. In rats, Gadodiamide did not affect fertility or general reproductive performance, and teratology studies in rats and rabbits showed no such effect at doses that did not cause maternal toxicity.

Use in Pregnancy: Pregnancy category B3. Reproductive performance in rats was unaffected at doses up to 1.0 mmol/kg. In rabbits, a higher proportion of litters showed skeletal or visceral abnormalities at doses of 0.5 and 1.0 mmol/kg, though this may reflect maternal toxicity rather than a direct effect of the drug itself. There are no adequate, well-controlled studies of Gadodiamide in pregnant women, so it should be used during pregnancy only if the expected benefit outweighs the potential risk to the foetus.

Use in Lactation: Whether Gadodiamide passes into human breast milk is not known. Breast-feeding should be stopped before the drug is given and should not resume until at least 24 hours after administration.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: No special preparation of the patient is required. Gadodiamide should be drawn into the syringe immediately before use. The vial is intended for one patient only. Any contrast medium not used in one examination must be discarded. Dosage for adults and children: The recommended dose is 0.1 mmol per kg body weight (equivalent to 0.2 ml per kg body weight) up to 100 kg. For patients above 100 kg body weight, 20 ml is usually enough to provide diagnostically adequate contrast. The required dose should be given as a single intravenous injection. To make sure the contrast medium is completely injected, the intravenous line may be flushed with 5 ml of 0.9% sodium chloride injection. Adults only: When brain metastases are suspected, a dose of 0.3 mmol per kg body weight (equivalent to 0.6 ml per kg body weight) can be given up to 100 kg. Above 100 kg body weight, a total of 60 ml is usually sufficient. This 0.3 mmol per kg dose can be given as a bolus intravenous injection. In patients whose scans remain unclear after the 0.1 mmol per kg injection, a second bolus injection of 0.2 mmol per kg body weight (equivalent to 0.4 ml per kg body weight) may add diagnostic value if given within 20 minutes of the first injection.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.

প্রধান পারস্পরিক ক্রিয়া

Checker →